Literature DB >> 2383078

Hereditary chondrocalcinosis in an Ashkenazi Jewish family.

G Eshel1, A Gulik, N Halperin, E Avrahami, H R Schumacher, D J McCarty, D Caspi.   

Abstract

A hereditary chondrocalcinosis is described for the first time in an Ashkenazi Jewish kindred. Of 34 family members in five generations, seven had medical history suggesting the disease. Five of 25 members of generations III-V had direct evidence for their disease. Characteristically, symptoms started at a fairly early age (third decade) while radiological evidence of chondrocalcinosis was delayed to the fourth decade. Joints commonly affected were knees, wrists, and elbows. The course was chronic with acute, exercise induced exacerbations.

Entities:  

Mesh:

Year:  1990        PMID: 2383078      PMCID: PMC1004143          DOI: 10.1136/ard.49.7.528

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  CHONDROCALCINOSIS (PSEUDOGOUT SYNDROME). A FAMILY STUDY.

Authors:  R W MOSKOWITZ; D KATZ
Journal:  JAMA       Date:  1964-06-08       Impact factor: 56.272

Review 2.  Calcium pyrophosphate dihydrate crystal deposition disease--1975.

Authors:  D J McCarty
Journal:  Arthritis Rheum       Date:  1976 May-Jun

3.  A hereditary type of idiopathic articular chondrocalcinosis. Survey of a pedigree.

Authors:  J K van der Korst; J Geerards; F C Driessens
Journal:  Am J Med       Date:  1974-03       Impact factor: 4.965

4.  [Familial pseudogout with destructive arthropathy (author's transl)].

Authors:  M Sakaguchi; K Ishikawa; H Mizuta; T Kitagawa
Journal:  Ryumachi       Date:  1982-02

5.  Hereditary diffuse articular chondrocalcinosis. Dominant manifestation without close linkage with the HLA system in a large pedigree.

Authors:  A Gaucher; G Faure; P Netter; J Pourel; C Raffoux; F Streiff; M M Tongio; S Mayer
Journal:  Scand J Rheumatol       Date:  1977       Impact factor: 3.641

6.  [Hereditary chondrocalcinosis. An examination of one family].

Authors:  H Asshoff; P Böhm; E Schoen; K Schürholz
Journal:  Humangenetik       Date:  1966

7.  Chondrocalcinosis in elderly persons.

Authors:  M H Ellman; B Levin
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

8.  Localised chondrocalcinosis in post-meniscectomy knees.

Authors:  M Doherty; I Watt; P A Dieppe
Journal:  Lancet       Date:  1982-05-29       Impact factor: 79.321

9.  Familial chondrocalcinosis. Prevalence in Northern Spain and clinical features in five pedigrees.

Authors:  V Rodriguez-Valverde; T Tinture; M Zuñiga; J Peña; A Gonzalez
Journal:  Arthritis Rheum       Date:  1980-04

10.  Familial articular chondrocalcinosis in Quebec.

Authors:  A Gaudreau; M Camerlain; M L Pibarot; G Beauregard; A Lebrun; C Petitclerc
Journal:  Arthritis Rheum       Date:  1981-04
View more
  5 in total

Review 1.  Familial and clinical aspects of calcium pyrophosphate deposition disease.

Authors:  A J Reginato; E Tamesis; P Netter
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.

Authors:  L J Andrew; V Brancolini; L S de la Pena; M Devoto; F Caeiro; R Marchegiani; A Reginato; A Gaucher; P Netter; P Gillet; D Loeuille; D J Prockop; A Carr; B F Wordsworth; M Lathrop; S Butcher; E Considine; K Everts; A Nicod; S Walsh; C J Williams
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

3.  Mutations in osteoprotegerin account for the CCAL1 locus in calcium pyrophosphate deposition disease.

Authors:  C J Williams; U Qazi; M Bernstein; A Charniak; C Gohr; E Mitton-Fitzgerald; A Ortiz; L Cardinal; A T Kaell; A K Rosenthal
Journal:  Osteoarthritis Cartilage       Date:  2018-03-22       Impact factor: 6.576

4.  Linkage of early-onset osteoarthritis and chondrocalcinosis to human chromosome 8q.

Authors:  C T Baldwin; L A Farrer; R Adair; R Dharmavaram; S Jimenez; L Anderson
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

Review 5.  Genetic factors in the pathogenesis of CPPD crystal deposition disease.

Authors:  Ana Rita Couto; Matthew A Brown
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.